Mitamark 7.5mg Tablet
Marketer
Triko Pharmaceuticals
Salt Composition
Mirtazapine (7.5mg)
Overview Mitamark 7.5mg Tablet
Deprexis 7.5mg tablets effectively manage depressive symptoms. Their mechanism involves boosting brain levels of serotonin and noradrenaline, neurotransmitters crucial for mood regulation and nerve relaxation. Deprexis 7.5mg can be administered with or without food; consistent daily dosing ensures stable blood levels. Missed doses should be taken promptly upon recall; complete the prescribed course regardless of symptom improvement. Abrupt cessation is inadvisable due to potential symptom exacerbation. Commonly reported side effects include xerostomia, increased hunger, and cephalalgia, alongside potential somnolence and vertigo. Refrain from operating machinery or engaging in tasks requiring concentration until the drug's effects are understood. Weight gain is a possibility; maintain a healthy diet and exercise routine. Report any fever or pharyngitis to your physician immediately.
Uses of Mitamark 7.5mg Tablet
Managing Depressive Disorders
Major Benefits of Mitamark 7.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mitamark 7.5mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Mitamark 7.5mg Tablet:
- Sleepiness
- Dryness in mouth
- Increased appetite
- Headache
- Weight gain
How to use Mitamark 7.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not crush, chew, or divide it. Mitamark 7.5mg Tablets can be ingested with or without food, although consistent timing is recommended.
How Mitamark 7.5mg Tablet works:
Deprexis 7.5mg tablets are prescribed for depression. Their mechanism involves elevating brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Mitamark 7.5mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Mitamark 7.5mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential benefits against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Nursing mothers should likely avoid Mitamark 7.5mg tablets. Preliminary data indicates potential transfer to breast milk, posing a risk to infants. Close observation of the infant for developmental issues and growth is recommended.
DrivingUNSAFE
Driving may be affected by Mitamark 7.5mg Tablets, which can induce side effects that reduce concentration and alertness.
KidneyCAUTION
For individuals with kidney impairment, the use of 7.5mg Mitamark tablets requires careful monitoring. Dosage modification of Mitamark 7.5mg tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Mitamark 7.5mg tablets. Dosage modification of Mitamark 7.5mg tablets may be necessary. Physician consultation is recommended.
What if you forget to take Mitamark 7.5mg Tablet :
Should you forget a Mitamark 7.5mg Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Mitamark 7.5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Tetracyclic Piperazinoazepine |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | Norepinephrine and serotonin-specific antidepressants (NaSSAs) |
3,018 People bought this recently